Cardiopulmonary autotransfusion systems: Key market research findings
- The Americas dominate the market geographically
- ASCs account for majority share of the market revenue
- Key vendors – Advancis Surgical, Fresenius Kabi, Haemonetics, LivaNova, Medtronic, and Terumo
Technavio’s market research analysts predict the global cardiopulmonary autotransfusion systems market to grow at a CAGR of around 2% between 2016 and 2020. The complications involved with allogenic blood transfusion drives growth in this market. Research studies on allogenic blood transfusion report that the blood type may carry pathogens or viruses for AIDS and hepatitis. Furthermore, allogenic transfusion can cause renal failure, stroke, atrial fibrillation, and myocardial infarction. During 2015, the Americas dominated the global cardiopulmonary autotransfusion systems market by accounting for over 45% of the overall market share. The rising prevalence of cardiovascular diseases (CVDs), advancements in technology, and increasing investments in R&D are some of the factors that will propel growth in the cardiopulmonary autotransfusion systems market in the Americas during the forecast period.
The new market research report from Technavio presents a breakdown and analysis of cardiopulmonary autotransfusion systems segments based on the end-user.
“The development of ultrafiltration systems is an upcoming trend in the market. Most vendors in the market are focusing on developing modified ultrafiltration-based systems to strengthen their foothold in the competitive market. This is expected to stimulate an increased demand for ultrafiltration systems in the coming years,” says Barath Palada, Lead Analyst, Healthcare & Lifesciences, Technavio Research.
During 2015, ambulatory surgical centers (ASCs) accounted for around 63% of the overall market share to become the dominant shareholder in the cardiopulmonary autotransfusion systems market globally. ASCs provide a wide range of medical services and conducts surgical and non-surgical procedures through outpatient settings, resulting in reduced medical expenses for the patient. The concept of ASCs is become increasingly popular as they have advanced operating equipment, specialist surgeons, and operating and recovery rooms without complex administrative procedures, which are usually time consuming and increase medical expenses in hospitals.
The key vendors in the market include Advancis Surgical, Fresenius Kabi, Haemonetics, LivaNova, Medtronic, and Terumo. This market is highly competitive with the presence of global and local players who provide a wide range of systems and components as per the preference and requirement of cardiac surgeons and physicians. Vendors are using advanced technologies to manufacture innovative products such as ultrafiltration systems and blood collection bags or reservoirs, and increase their market reach across the globe.
A more detailed analysis is available in the Technavio report, Global Cardiopulmonary Autotransfusion Systems Market 2016-2020.
We can customize reports by other regions and specific segments upon request.
Other related reports:
